Zhaojun Yin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Zhaojun Yin has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Xuefei Huang
Michigan State University
4 shared publications - Bo Wang
Interconnected & Integrated Bioelectronics Lab (I2BL) Department of Electrical and Computer Engineering University of California Los Angeles CA 90095 USA
3 shared publications Xiang-Bao Meng
The State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, P. R. China
3 shared publications- Zhongjun Li
State Key Laboratory of Natural and Biomimetic Drugs, Chemical Biology Center, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences Peking University Beijing China
3 shared publications - Xiangbao Meng
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China
2 shared publications Yangbing Li
2 shared publications
Latest Publications
- 1 September 2015
- Published by Elsevier in Tetrahedron Letters
- Vol. 56 (37) , 5228-5230
Concise and direct construction of cis-pyrano[4,3-b]pyran-5-one skeleton from glucal derivatives: synthesis of ent-4-deoxy-2,3-di-epi-dinemasone BC
- 1 September 2015
- Published by Elsevier in Tetrahedron Letters
- Vol. 56 (37) , 5228-5230
Concise and direct construction of cis-pyrano[4,3-b]pyran-5-one skeleton from glucal derivatives: synthesis of ent-4-deoxy-2,3-di-epi-dinemasone BC
- 7 September 2012
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 51 (40) , 10185-10189
Chemical Synthesis of a Heparan Sulfate Glycopeptide: Syndecan‐1
Finishing first: The highly complex structure of the title compound (see picture) was assembled. The protective groups utilized, as well as the sequences for formation of the glycosyl linkages and protecting group removal are critical to the success of the synthesis. This first preparation of a heparan sulfate glycopeptide lays the foundation for accessing other members of this class of molecules.
- 7 September 2012
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 51 (40) , 10185-10189
Chemical Synthesis of a Heparan Sulfate Glycopeptide: Syndecan‐1
Finishing first: The highly complex structure of the title compound (see picture) was assembled. The protective groups utilized, as well as the sequences for formation of the glycosyl linkages and protecting group removal are critical to the success of the synthesis. This first preparation of a heparan sulfate glycopeptide lays the foundation for accessing other members of this class of molecules.
- 2 August 2012
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 23 (8) , 1694-1703
Tobacco Mosaic Virus as a New Carrier for Tumor Associated Carbohydrate Antigens
Tumor-associated carbohydrate antigens (TACAs) are being actively studied as targets for antitumor vaccine development. One serious challenge was the low immunogenecity of these antigens. Herein, we report the results of using the tobacco mosaic virus (TMV) capsid as a promising carrier of a weakly immunogenic TACA, the monomeric Tn antigen. The copper(I) catalyzed azide–alkyne cycloaddition reaction was highly efficient in covalently linking Tn onto the TMV capsid without resorting to a large excess of the Tn antigen. The location of Tn attachment turned out to be important. Tn introduced at the N terminus of TMV was immunosilent, while that attached to tyrosine 139 elicited strong immune responses. Both Tn specific IgG and IgM antibodies were generated as determined by enzyme-linked immunosorbent assay and a glycan microarray screening study. The production of high titers of IgG antibodies suggested that the TMV platform contained the requisite epitopes for helper T cells and was able to induce antibody isotype switching. The antibodies exhibited strong reactivities toward Tn antigen displayed in its native environment, i.e., cancer cell surface, thus highlighting the potential of TMV as a promising TACA carrier.
- 2 August 2012
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 23 (8) , 1694-1703
Tobacco Mosaic Virus as a New Carrier for Tumor Associated Carbohydrate Antigens
Tumor-associated carbohydrate antigens (TACAs) are being actively studied as targets for antitumor vaccine development. One serious challenge was the low immunogenecity of these antigens. Herein, we report the results of using the tobacco mosaic virus (TMV) capsid as a promising carrier of a weakly immunogenic TACA, the monomeric Tn antigen. The copper(I) catalyzed azide–alkyne cycloaddition reaction was highly efficient in covalently linking Tn onto the TMV capsid without resorting to a large excess of the Tn antigen. The location of Tn attachment turned out to be important. Tn introduced at the N terminus of TMV was immunosilent, while that attached to tyrosine 139 elicited strong immune responses. Both Tn specific IgG and IgM antibodies were generated as determined by enzyme-linked immunosorbent assay and a glycan microarray screening study. The production of high titers of IgG antibodies suggested that the TMV platform contained the requisite epitopes for helper T cells and was able to induce antibody isotype switching. The antibodies exhibited strong reactivities toward Tn antigen displayed in its native environment, i.e., cancer cell surface, thus highlighting the potential of TMV as a promising TACA carrier.
- 1 August 2012
- Published by Elsevier in Tetrahedron
- Vol. 68 (34) , 6981-6989
Synthesis of orthogonally protected l-glucose, l-mannose, and l-galactose from d-glucose
- 1 August 2012
- Published by Elsevier in Tetrahedron
- Vol. 68 (34) , 6981-6989
Synthesis of orthogonally protected l-glucose, l-mannose, and l-galactose from d-glucose
- 29 February 2012
- Published by Taylor & Francis in Journal of Carbohydrate Chemistry
- Vol. 31 (3) , 143-186
Recent Development in Carbohydrate Based Anticancer Vaccines
The development of carbohydrate-based anticancer vaccines is of high current interest. Herein, the latest development in this exciting field is reviewed. After a general introduction about tumor-associated carbohydrate antigens and immune responses, the review focuses on the various strategies that have been developed to enhance the immunogenicity of these antigens. The results from animal studies and clinical trials are presented.
- 29 February 2012
- Published by Taylor & Francis in Journal of Carbohydrate Chemistry
- Vol. 31 (3) , 143-186
Recent Development in Carbohydrate Based Anticancer Vaccines
The development of carbohydrate-based anticancer vaccines is of high current interest. Herein, the latest development in this exciting field is reviewed. After a general introduction about tumor-associated carbohydrate antigens and immune responses, the review focuses on the various strategies that have been developed to enhance the immunogenicity of these antigens. The results from animal studies and clinical trials are presented.
- 14 October 2011
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 76 (22) , 9531-9535
Active Cobalt Catalyst for the Cleavage of Benzyl Ether
An improved method for the deprotection of benzyl ethers using a catalytic amount of Co2(CO)8 in the presence of Me2PhSiH and CO (1 atm) is described. The deprotection reaction is compatible with double bond or sulfur-containing substrates. The method also tolerates other functional groups, such as Ac, Piv, and Bz, and shows potential selectivity in perbenzylated monosaccharides.
- 14 October 2011
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 76 (22) , 9531-9535
Active Cobalt Catalyst for the Cleavage of Benzyl Ether
An improved method for the deprotection of benzyl ethers using a catalytic amount of Co2(CO)8 in the presence of Me2PhSiH and CO (1 atm) is described. The deprotection reaction is compatible with double bond or sulfur-containing substrates. The method also tolerates other functional groups, such as Ac, Piv, and Bz, and shows potential selectivity in perbenzylated monosaccharides.
- 22 July 2011
- Published by Wiley in Chemistry – A European Journal
- Vol. 17 (36) , 10106-10112
Divergent Heparin Oligosaccharide Synthesis with Preinstalled Sulfate Esters
Traditional chemical synthesis of heparin oligosaccharides first involves assembly of the full length oligosaccharide backbone followed by sulfation. Herein, we report an alternative strategy in which the O‐sulfate was introduced onto glycosyl building blocks as a trichloroethyl ester prior to assembly of the full length oligosaccharide. This allowed divergent preparation of both sulfated and non‐sulfated building blocks from common advanced intermediates. The O‐sulfate esters were found to be stable during glycosylation as well as typical synthetic manipulations encountered during heparin oligosaccharide synthesis. Furthermore, the presence of sulfate esters in both glycosyl donors and acceptors did not adversely affect the glycosylation yields, which enabled us to assemble multiple heparin oligosaccharides with preinstalled 6‐O‐sulfates.
- 22 July 2011
- Published by Wiley in Chemistry – A European Journal
- Vol. 17 (36) , 10106-10112
Divergent Heparin Oligosaccharide Synthesis with Preinstalled Sulfate Esters
Traditional chemical synthesis of heparin oligosaccharides first involves assembly of the full length oligosaccharide backbone followed by sulfation. Herein, we report an alternative strategy in which the O‐sulfate was introduced onto glycosyl building blocks as a trichloroethyl ester prior to assembly of the full length oligosaccharide. This allowed divergent preparation of both sulfated and non‐sulfated building blocks from common advanced intermediates. The O‐sulfate esters were found to be stable during glycosylation as well as typical synthetic manipulations encountered during heparin oligosaccharide synthesis. Furthermore, the presence of sulfate esters in both glycosyl donors and acceptors did not adversely affect the glycosylation yields, which enabled us to assemble multiple heparin oligosaccharides with preinstalled 6‐O‐sulfates.
- 8 January 2010
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 12 (3) , 536-539
Highly Efficient and Mild Method for Regioselective De-O-benzylation of Saccharides by Co2(CO)8-Et3SiH−CO Reagent System
A highly efficient and mild method for the de-O-benzylation of protected saccharides was developed by transforming terminal benzyl ethers into silyl ethers using Co2(CO)8-Et3SiH under 1 atm of CO. The method was successfully used for the de-O-benzylation of perbenzylated monosaccharides with various anomeric protecting groups, as well as natural disaccharides and trisaccharides such as sucrose, raffinose, and melezitose in good yields (>80%).
- 8 January 2010
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 12 (3) , 536-539
Highly Efficient and Mild Method for Regioselective De-O-benzylation of Saccharides by Co2(CO)8-Et3SiH−CO Reagent System
A highly efficient and mild method for the de-O-benzylation of protected saccharides was developed by transforming terminal benzyl ethers into silyl ethers using Co2(CO)8-Et3SiH under 1 atm of CO. The method was successfully used for the de-O-benzylation of perbenzylated monosaccharides with various anomeric protecting groups, as well as natural disaccharides and trisaccharides such as sucrose, raffinose, and melezitose in good yields (>80%).
- 28 December 2007
- Published by Elsevier in Carbohydrate Research
- Vol. 342 (18) , 2729-2734
Design and synthesis of novel multivalent mannosides targeting the mannose receptor
- 28 December 2007
- Published by Elsevier in Carbohydrate Research
- Vol. 342 (18) , 2729-2734
Design and synthesis of novel multivalent mannosides targeting the mannose receptor